Shammana N Muddukrishna

Shammana N Muddukrishna is a prominent inventor based in Carlsbad, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of biologically safe KLH products used for cancer treatment. With a total of 2 patents, her work is paving the way for advancements in therapeutic vaccines.

Latest Patents

Shammana's latest patents focus on preparation methods for a novel generation of biologically safe KLH products. These products are essential for cancer treatment and the development of conjugated therapeutic vaccines. One of her inventions relates to the provision of biologically safe hemolymph sera, specifically hemocyanin, with a preference for KLH (keyhole limpet hemocyanin). The hemocyanin is purified using anion exchange chromatography, ensuring its safety and efficacy. Additionally, she has developed a method for producing virus-free hemocyanin, further enhancing the potential applications of her work.

Career Highlights

Shammana is currently associated with Biosyn Arzneimittel GmbH, where she continues to innovate and contribute to the field of biotechnology. Her expertise in hemolymph sera and KLH products has positioned her as a key player in the development of cancer therapies.

Collaborations

Shammana has collaborated with notable colleagues, including Ortwin Kottwitz and Thomas Stiefel. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in her field.

Conclusion

Shammana N Muddukrishna is a trailblazer in the biotechnology sector, with her inventions significantly impacting cancer treatment methodologies. Her dedication to developing biologically safe KLH products showcases her commitment to advancing medical science.

Profile summary based on public USPTO records.